以中耳炎为首发表现的抗中性粒细胞胞浆抗体相关血管炎临床特征
Otitis media as initial manifestation of antineutrophil cytoplasmic antibody-associated vasculitis
林颖;乔燕;杨润琴;徐卓;查定军
1:空军军医大学第一附属医院耳鼻咽喉头颈外科
摘要关键词基金项目(Foundation):作者参考文献[1] COATES M L,MARTINEZ DEL PERO M.Updates in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis for the ENT surgeon[J].Clin Otolaryngol,2020,45:316-326.
[2] 原渕保明，飯野ゆき子岸，部幹.ANCA関連血管炎性中耳炎[otitis media with ANCA associated vasculitis(OMAAV)]の診断基準(案)[J].Otol JPN,2013,23(3):279-281.
[3] HARABUCHI Y,KISHIBE K,TATEYAMA K,et al.Clinical characteristics,the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society[J].Auris Nasus Larynx,2021,48(1):2-14.
[4] 张志坚，任杰，曹永茂，等.抗中性粒细胞胞浆抗体(ANCA)相关血管炎性中耳炎的诊治分析[J].听力学及言语疾病杂志，2022,30(6):617-622.
[5] FUJIWARA K,MORITA S,FUKUDA A,et al.Characteristics of and prognosis for facial palsy in patients with otitis media with ANCA-associated vasculitis (OMAAV)[J].Otol Neurotol,2021,42(10):e1577-e1582.
[6] HARABUCHI Y,KISHIBE K,TATEYAMA K,et al.Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV):a retrospective analysis of 235 patients from a nationwide survey in Japan[J].Mod Rheumatol,2017,27(1):87-94.
[7] YOSHIDA NIINO Y.Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis[J].Allergol Int,2014,63(4):523-532.
[8] KOBARI Y,NAGASAWA T.Otitis media with ANCA-associated vasculitis:a new concept and the associated criteria[J].Intern Med,2017,56(24):3365-3367.
[9] 林丹宇，申宇鹏，李晓明，等.以分泌性中耳炎为首诊症状的 ANCA 相关小血管炎的临床误诊2例[J].临床与病理杂志，2018,38(12):2738-2742.
[10] MORITA Y,TAKAHASHI K,IZUMI S,et al.Vestibular involvement in patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis[J].Otol Neurotol,2017,38(1):97-101.
[11] SUPPIAH R,HADDEN RD FAU-BATRA R,BATRA R FAU-ARDEN N K,et al.Peripheral neuropathy in ANCA-associated vasculitis:outcomes from the European Vasculitis Study Group trials[J].Rheumatology (Oxford),2011,50(12):2214-2222.
[12] YOKOSEKI A,SAJI E,ARAKAWA M,et al.Hypertrophic pachymeningitis:significance of myeloperoxidase anti-neutrophil cytoplasmic antibody[J].Brain,2014,137(Pt 2):520-536.
[13] SAKAIRI T,SAKURAI N,NAKASATOMI M,et al.Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis:a case series of 15 patients[J].Scand J Rheumatol,2019,48(3):218-224.
[14] PENG A,YANG X,WU W,et al.Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media:a review of literature[J].Eur Arch Otorhinolaryngol,2018,275(12):2915-2923.
[15] YOSHIDA N,HARA M,HASEGAWA M,et al.Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms[J].Otol Neurotol,2014,35(1):114-120.
[16] OKADA M,SUEMORI K,TAKAGI D,et al.The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis[J].Auris Nasus Larynx,2019,46(1):38-42.
[17] NIKOLAOU A C,VLACHTSIS K C,DANIILIDIS M A,et al.Wegener's granulomatosis presenting with bilateral facial nerve palsy[J].Eur Arch Otorhinolaryngol,2001,258(4):198-202.
[18] 刘韵，王振晓，王林娥，等.中性粒细胞胞浆抗体相关性中耳炎误诊病例临床特点分析[J].临床和实验医学杂志，2017,16(4):399-401.